Hudson Bay Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-95,000
Closed -$72.5M 1383
2025
Q3
$72.5M Buy
95,000
+92,200
+3,293% +$68.6M 0.24% 72
2025
Q2
$2.18M Buy
+2,800
New +$2.18M 0.01% 768
2025
Q1
Sell
-40,000
Closed -$30.9M 1403
2024
Q4
$30.9M Buy
+40,000
New +$33.1M 0.11% 185

Other funds holding LLY

Hudson Bay Capital Management's LLY Position: Q1 2026 in Review

Hudson Bay Capital Management increased its Eli Lilly (LLY) stake by 167% in Q1 2026, buying an estimated $42.5M and bringing the position to 67,004 shares worth $61.6M. The position accounts for 0.21% of the portfolio, ranked #85.

Hudson Bay Capital Management first reported a position in LLY in Q1 2021 and has held it in 13 quarters since. The position peaked at $353M in Q2 2024. 4,356 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Hudson Bay Capital Management held 67,004 shares of Eli Lilly worth $61.6M as of Q1 2026.
  • Hudson Bay Capital Management bought 41,884 Eli Lilly shares in Q1 2026, an estimated $42.5M.
  • Eli Lilly made up 0.21% of Hudson Bay Capital Management's portfolio in Q1 2026, its #85 holding.
  • Hudson Bay Capital Management first reported a position in Eli Lilly in Q1 2021 and has held it in 13 quarters since.
  • Hudson Bay Capital Management's Eli Lilly position peaked at $353M in Q2 2024.
  • 4,356 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.